02898.HK
Sunho Biologics, Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 6.40
+0.00%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -77.2%
- EBITDA
- +23.0%
- EBIT
- -53.1%
- Net income
- +39.7%
- EPS
- +56.6%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2025